Today in Sacramento, state regulators are meeting to discuss tightening regulations on compounding pharmacies. This comes after 24 people died and more than 300 became ill after receiving contaminated steroid injections produced at a pharmacy in Massachusetts.
Here in California, public health officials estimate that about 600 patients received contaminated injections from that facility, but so far no one here has fallen ill.
Could the deaths have been prevented by stricter regulations on compounding pharmacies?
Here to help us answer that question is Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute.